Beckman Daniella
SEC-identified person · CIK 1513422 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Vor Biopharma Inc. VOR | Director | filed 2021–2026 |
| Upstream Bio, Inc. UPB | Director | filed 2024–2026 |
| Tango Therapeutics, Inc. TNGX | Chief Financial Officer | filed 2021–2026 |
| Blueprint Medicines Corp BPMC | Director | filed 2022–2025 |
| Translate Bio, Inc. TBIO | Director | filed 2018–2021 |
| 5:01 Acquisition Corp. FVAM | Director | filed 2020–2020 |
| Idenix Pharmaceuticals INC IDIX | VP, CFO and Treasurer | filed 2011–2014 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.